Stock Market News1 week J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug Zacks
JNJ’s regulatory filing seeks the FDA’s approval for TAR-200, a drug-device combination for treating certain bladder cancer patients.
XJNJ’s regulatory filing seeks the FDA’s approval for TAR-200, a drug-device combination for treating certain bladder cancer patients.
X